BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30
• 31

• Biotech Bay

  Amgen to Present at the Bank of America Merrill Lynch Global Healthcare Conference 2024

  Amgen will present at the Bank of America Merrill Lynch Global Healthcare Conference at 9:20 a.m. PT on Tuesday, May 14, 2024.

  May 9, 2024

   · 

  2 min read
• Business

  Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results

  Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced financial results for the quarter ended March 31, 2024.

  May 9, 2024

   · 

  10 min read
• Business

  Oncolytics Biotech® Reports First Quarter 2024 Financial Results and Operational Highlights

  Oncolytics Biotech® Inc., a leading clinical-stage company specializing in immunotherapy for oncology, announced recent operational highlights and financial results for the first quarter ended March 31, 2024.

  May 9, 2024

   · 

  15 min read
• Business

  Regulus Therapeutics Reports First Quarter 2024 Financial Results and Recent Updates

  Regulus Therapeutics Inc., a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, reported financial results for the first quarter ended March 31, 2024, and provided a corporate update.

  May 9, 2024

   · 

  8 min read
• Business

  Arcellx Provides First Quarter 2024 Financial Results

  Arcellx, Inc., a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, reported business highlights and financial results for the first quarter ended March 31, 2024.

  May 9, 2024

   · 

  5 min read
• Business

  Alpine Immune Sciences Reports First Quarter 2024 Financial Results

  Alpine Immune Sciences, Inc., a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, reported financial results for the first quarter ended March 31, 2024.

  May 9, 2024

   · 

  9 min read
• Business

  Ginkgo Bioworks Reports First Quarter 2024 Financial Results

  Ginkgo Bioworks Holdings, Inc., which is building the leading platform for cell programming and biosecurity, announced its results for the first quarter ended March 31, 2024.

  May 9, 2024

   · 

  19 min read
• Business

  Tyra Biosciences Reports First Quarter 2024 Financial Results and Highlights

  Tyra Biosciences, Inc. reported financial results for the quarter ended March 31, 2024, and highlighted recent corporate progress.

  May 9, 2024

   · 

  11 min read
• Business

  SenesTech Announces First Quarter 2024 Financial Results

  SenesTech, Inc., the leader in fertility control to manage animal pest populations and the only manufacturer of commercially available, EPA-registered Rat Birth Control® products announced financial results for the first quarter of 2024.

  May 9, 2024

   · 

  9 min read
• Business

  PacBio Announces First Quarter 2024 Financial Results

  PacBio announced financial results for the quarter ended March 31, 2024.

  May 9, 2024

   · 

  14 min read